National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada.
Outstanding track record with imperfect balance sheet.
Share Price & News
How has National Research's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: NRC's share price has been volatile over the past 3 months.
7 Day Return
1 Year Return
Return vs Industry: NRC underperformed the US Healthcare industry which returned 18.7% over the past year.
Return vs Market: NRC exceeded the US Market which returned 7.1% over the past year.
Price Volatility Vs. Market
How volatile is National Research's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StIs National Research Corporation’s (NASDAQ:NRC) 57% ROCE Any Good?
2 weeks ago | Simply Wall StDoes National Research Corporation's (NASDAQ:NRC) Recent Track Record Look Strong?
4 weeks ago | Simply Wall StKey Things To Consider Before Buying National Research Corporation (NASDAQ:NRC) For Its Dividend
Is National Research undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: NRC ($56.07) is trading above our estimate of fair value ($27.3)
Significantly Below Fair Value: NRC is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: NRC is poor value based on its PE Ratio (38.9x) compared to the Healthcare industry average (24x).
PE vs Market: NRC is poor value based on its PE Ratio (38.9x) compared to the US market (15.6x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate NRC's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: NRC is overvalued based on its PB Ratio (37.7x) compared to the US Healthcare industry average (3x).
How is National Research forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as National Research has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
- Check out National Research's track record over time to understand how much the company has returned to shareholders and its earnings growth rate in the past.
- Explore growth companies in the Healthcare industry.
How has National Research performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: NRC has high quality earnings.
Growing Profit Margin: NRC's current net profit margins (27.5%) are higher than last year (25.7%).
Past Earnings Growth Analysis
Earnings Trend: NRC's earnings have grown by 15.8% per year over the past 5 years.
Accelerating Growth: NRC's earnings growth over the past year (16.3%) exceeds its 5-year average (15.8% per year).
Earnings vs Industry: NRC earnings growth over the past year (16.3%) exceeded the Healthcare industry 10.1%.
Return on Equity
High ROE: NRC's Return on Equity (96.4%) is considered outstanding.
How is National Research's financial position?
Financial Position Analysis
Short Term Liabilities: NRC's short term assets ($34.9M) do not cover its short term liabilities ($39.9M).
Long Term Liabilities: NRC's short term assets ($34.9M) do not cover its long term liabilities ($38.7M).
Debt to Equity History and Analysis
Debt Level: NRC's debt to equity ratio (89.1%) is considered high.
Reducing Debt: NRC's debt to equity ratio has increased from 8.5% to 89.1% over the past 5 years.
Debt Coverage: NRC's debt is well covered by operating cash flow (117.8%).
Interest Coverage: NRC's interest payments on its debt are well covered by EBIT (22.4x coverage).
What is National Research's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: NRC's dividend (1.5%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.71%).
High Dividend: NRC's dividend (1.5%) is low compared to the top 25% of dividend payers in the US market (4.54%).
Stability and Growth of Payments
Stable Dividend: NRC has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: NRC has only been paying a dividend for 5 years, and since then payments have fallen.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (55.5%), NRC's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mike Hays (64yo)
Mr. Michael D. Hays, also known as Mike, serves as an Advisor of Picker Institute Inc. Mr. Hays founded National Research Corp. in 1981 and has been its Chief Executive Officer since 1981. Mr. Hays served ...
CEO Compensation Analysis
Compensation vs Market: Mike's total compensation ($USD233.88K) is below average for companies of similar size in the US market ($USD4.80M).
Compensation vs Earnings: Mike's compensation has been consistent with company performance over the past year.
|Senior VP of Finance||8.67yrs||US$520.05k||0.070% $985.5k|
|Vice President of Finance||no data||no data||no data|
Experienced Management: NRC's management team is seasoned and experienced (8.7 years average tenure).
|Lead Independent Director||8yrs||US$175.00k||0.11% $1.5m|
|Independent Director||18.92yrs||US$150.00k||1.09% $15.4m|
|Independent Director||4.58yrs||US$150.00k||no data|
Experienced Board: NRC's board of directors are seasoned and experienced ( 13.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
National Research Corporation's company bio, employee growth, exchange listings and data sources
- Name: National Research Corporation
- Ticker: NRC
- Exchange: NasdaqGS
- Founded: 1981
- Industry: Health Care Services
- Sector: Healthcare
- Market Cap: US$1.409b
- Shares outstanding: 25.13m
- Website: https://nrchealth.com
Number of Employees
- National Research Corporation
- 1245 Q Street
- United States
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|NRC||NasdaqGS (Nasdaq Global Select)||Yes||Common Stock||US||USD||May 2013|
|NR1A||BST (Boerse-Stuttgart)||Yes||Common Stock||DE||EUR||May 2013|
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, health risk assessments, employee engagement, reputation management, and brand loyalty. The company also offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. Further, the company offers transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, enhance patient satisfaction and support safe care transitions; and health risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs. Additionally, it provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems, post-acute providers, and payer organizations. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/05/28 05:41|
|End of Day Share Price||2020/05/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.